Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation
- PMID: 9685238
- DOI: 10.1021/jm970819w
Antiviral activities of methylated nordihydroguaiaretic acids. 1. Synthesis, structure identification, and inhibition of tat-regulated HIV transactivation
Abstract
Nordihydroguaiaretic acid (NDGA, meso-1) possesses four phenolic hydroxyl groups. Treatment of NDGA with 0.50-4.1 equiv of dimethyl sulfate and 3.0-6.0 equiv of potassium carbonate in acetone at 56 degrees C gave nine methylated products. Eight of those mono-, di-, tri-, and tetra-O-methylated NDGAs were isolated in pure form, and their structures were identified unambiguously by spectroscopic methods. A preparative amount of tetramethyl NDGA M4N (10) was obtained in 99% yield from NDGA by use of 4.1 equiv of dimethyl sulfate for the methylation. Among the eight different methylated NDGAs (2-6 and 8-10), tetra-O-methyl-NDGA (10) showed the strongest anti-HIV activity (IC50 11 microM). Chemically synthesized 3'-O-methyl-NDGA ((+/-)-2) showed identical anti-HIV activity (IC50 25 microM) to the lignan isolated from Creosote Bush. Lignans with methylated catecholic hydroxyl groups can be produced in large quantities with low cost. At drug concentrations below 30 microM tetramethyl NDGA (10) was a stronger anti-HIV agent than mono- and dimethylated NDGAs.
Similar articles
-
New nordihydroguaiaretic acid derivatives as anti-HIV agents.Bioorg Med Chem Lett. 2008 Mar 15;18(6):1884-8. doi: 10.1016/j.bmcl.2008.02.018. Epub 2008 Feb 10. Bioorg Med Chem Lett. 2008. PMID: 18321703
-
Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.J Med Chem. 1998 Jul 30;41(16):3001-7. doi: 10.1021/jm980182w. J Med Chem. 1998. PMID: 9685239
-
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.Anticancer Drug Des. 2001 Dec;16(6):261-70. Anticancer Drug Des. 2001. PMID: 12375879
-
Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs.Curr Cancer Drug Targets. 2020;20(2):86-103. doi: 10.2174/1568009619666191022141547. Curr Cancer Drug Targets. 2020. PMID: 31642411 Review.
-
Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases.Front Pharmacol. 2020 Feb 28;11:151. doi: 10.3389/fphar.2020.00151. eCollection 2020. Front Pharmacol. 2020. PMID: 32184727 Free PMC article. Review.
Cited by
-
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression.Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13239-44. doi: 10.1073/pnas.0405407101. Epub 2004 Aug 25. Proc Natl Acad Sci U S A. 2004. PMID: 15329416 Free PMC article.
-
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future.Cancer Biol Med. 2018 Nov;15(4):354-374. doi: 10.20892/j.issn.2095-3941.2018.0030. Cancer Biol Med. 2018. PMID: 30766748 Free PMC article.
-
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.Med Res Rev. 2016 Jan;36(1):32-91. doi: 10.1002/med.21377. Epub 2015 Sep 11. Med Res Rev. 2016. PMID: 26359649 Free PMC article. Review.
-
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR).Cell Rep Med. 2024 Jul 16;5(7):101630. doi: 10.1016/j.xcrm.2024.101630. Epub 2024 Jul 1. Cell Rep Med. 2024. PMID: 38955178 Free PMC article. Clinical Trial.
-
Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Biology (Basel). 2012 Nov 19;1(3):668-97. doi: 10.3390/biology1030668. Biology (Basel). 2012. PMID: 24832514 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical